Dupilumab With Medium-Dose Inhaled Corticosteroids Versus Omalizumab With High-Dose Inhaled Corticosteroids Improves Clinical Outcomes In Patients With Coexisting Chronic Rhinosinusitis With Nasal Polyps And Uncontrolled Asthma

Journal of Allergy and Clinical Immunology 2026 Open access

Read full text
Authors: Martin Wagenmann, ARNAUD AB BOURDIN, Rohit Katial, Michael Wechsler, Paramita Paramita Saha-Chaudhuri, Scott Nash, Mark Corbett, Rebecca Gall, Andrew H. Moraco, Anju Tripathi Peters
DOI: 10.1016/j.jaci.2025.12.909
Cited by: 0

Fields of Study & Subjects

Sinusitis and nasal conditions Asthma and respiratory diseases Allergic Rhinitis and Sensitization

Publication details

Journal / source
Journal of Allergy and Clinical Immunology
Volume
157
Issue
2
Pages
AB413–AB413
Publication date
1 February 2026
Language
EN